Agilent Technologies, Inc. is an analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Agilent has a long history of supporting the cancer research community. We know that when you provide creative scientists and physicians with the tools, they need to fight cancer, amazing things can happen. From new understandings of tumor genomic microheterogeneity, to increasingly powerful and precise therapies such as checkpoint inhibitors, to new companion diagnostics enabling personalized therapies and new diagnostic tools that can guide patient care decisions with more precision than ever–progress is happening. Wherever your research is in the pipeline, from the early discovery of cellular pathology to clinical trials to characterizing biologics in production or developing new diagnostic tools, Agilent is there.